ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 315

$360K Total Retail Price of All Prescriptions

Rank: 126 out of 315

250 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 5,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 281 273 1 2
SIMVASTATIN 269 258 2 1
METOPROLOL SUCCINATE 258 237 3 13
LOVASTATIN 233 231 4 8
LOSARTAN POTASSIUM 228 226 5 4
ATORVASTATIN CALCIUM 224 219 6 5
METFORMIN HCL ER 209 207 7 33
LEVOTHYROXINE SODIUM 199 169 8 6
LISINOPRIL 187 158 9 3
LOSARTAN-HYDROCHLOROTHIAZIDE 175 170 10 17
AMLODIPINE BESYLATE-BENAZEPRIL 146 134 11 26
METOPROLOL TARTRATE 130 115 12 18
PRAVASTATIN SODIUM 117 108 13 10
OMEPRAZOLE 107 105 14 9
ALENDRONATE SODIUM 104 104 15 12
FUROSEMIDE 102 91 16 15
HYDROCODONE-ACETAMINOPHEN 94 81 S3 17 19
METFORMIN HCL 94 80 17 7
DIGOXIN 93 91 19 45
FELODIPINE ER 81 81 20 23
TAMSULOSIN HCL 73 73 21 21
ALLOPURINOL 71 71 22 14
DONEPEZIL HCL 65 65 23 28
CRESTOR 64 64 24 24
ADVAIR DISKUS 63 54 25 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 62 26 50
GLIPIZIDE ER 60 60 27 55
DOXAZOSIN MESYLATE 60 51 27 110
NAMENDA 57 57 29 38
GABAPENTIN 56 47 30 37
WARFARIN SODIUM 54 46 31 20
HYDROCHLOROTHIAZIDE 50 49 32 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.